Timo Liebig leads Alvotech`s center of excellence for early development work. Timo oversees all activities from project initiation to process transfer, including cell line development, clone selection and upstream process development to produce high quality biosimilars. In addition, Timo is accountable for the Alvotech`s portfolio, driving Alvotech`s strategy towards product selection and having the head of project management group reporting to him.
Timo has ten-year exclusive experience in biosimilars, first in a contract manufacturing setting and thereafter at Alvotech. Timo is a biologist by training and graduated with a PhD in Molecular and Cell Biology from Imperial College of Science (London, UK) and MSc in regulatory affairs for biopharmaceuticals, EUCRAF / University of Strasbourg (France) before starting his career in the industry at Johnson & Johnson.